Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
NEWYou can now hear FOX News Articles!
Researchers of the San Carlos Clinical Hospital in Madrid may have called up a potential solution for hair loss.
A recently carried out study analyzed the effect of the injection Mice With stem cells from human fat “stem cells derived from fat (ASCS)”-as a means for the treatment of androgenetic alopecia (AGA), which are more common as hair loss of men or mason.
The team found that male mice achieved the best hair growth after three weeks when they received low -dosed ASCs, combined with an energy -strength molecule called adenosintriphosphate (ATP).
Hairdresser and medical expert confirm temporary hair loss that affect Ozempic users
Low-dosed and high-dose ASC treatments together with ATP led to an improvement in hair in women, but a medium dose of ASC Plus ATP led to a greater re-growing.
The researchers Castle to the conclusion that the regrowing of Haaren was improved in “all experimental groups” in which male mice received stem cell solutions that were supplemented with ATP.
Researchers from the San Carlos Clinical Hospital in Madrid may have rejected a potential solution for hair loss. (IStock)
The results were published in the magazine Stem Cell Research & Therapy.
The leading study author Dr. Eduardo López Bran – dermatologist and professor at the Complete University of Madrid – shared his expectations of the study in an interview with FOX News Digital.
This daily beauty routine could ruin your hair, warn experts
“We expected good results, but not so much success,” he said. “We speak of very high hair growth in both male and female mice.”
In the case of suitable doses, the researchers reached “very high percentages” of the hair, and found that 100% of the male mice and up to 90% of female mice rise hair.
In the case of suitable doses, the researchers reached “very high percentages” of the hair, and found that 100% of the male mice and up to 90% of female mice rise hair. (Actual mice from the study that is not shown.) (IStock)
“These results show that advanced therapies for many diseases, for which no effective treatments are currently available, are a new therapeutic approach,” continued Bran.
“Achieve such promising results in the Preclinical phase With a completely new approach to androgenetic alopecia – one that avoids chronic treatment and is also safe – is an important scientific milestone. “
“We speak of very high hair growth in both male and female mice.”
The main limitation of the study was the thinness of the mouse skin, found Bran, which was “a challenge in the administration of the therapy”.
Click here to get the FOX News app
“This required the development of protocols to minimize the experimental variability and is a key factor when studies begin,” he said.
“Research advances show possible solutions that can deliver permanent results in the future without continuous treatment necessary to maintain the advantages.” (IStock)
These new results should be “interpreted with caution and scientific strict”, warned Bran.
“Although the results of mice represent significant progress, it is also true that it is important to wait for the confirmation of clinical advantages in humans.”
Click here to register for our health newsletter
The researcher encouraged those with androgenetic alopecia to continue to advise and follow with their dermatologists prescribed treatments How research develops.
“It is important to remain hopeful. Research advances point to possible solutions that can deliver permanent results in the future without continuous treatment to be used to maintain the advantage,” added Bran.
“This study is low, and as a potential treatment option, more research on this method is required.”
With a view to the clinical studies of human studies, the researchers are actively working on confirming security for men and women between the ages of 18 and 50 with moderate androgenetic alopecia, according to the researcher.
“If everything progresses as expected, the most optimistic timeline shows on treatment in about five years,” he said.
With a view to the clinical studies, human studies “are actively working on confirming security for men and women between the ages of 18 and 50 with moderate androgenetic alopecia. (IStock)
In a separate interview with FOX News Digital, Dr. Brendan Camp, MD, a dermatologist based in New York who was not involved in the study, the potential for this method.
“Although this study is not available in stores, it suggests that the injection of stem cells supplemented with ATP in scalp may be able to promote the back up of hair with androgenetic alopecia,” he repeated.
You can find more health articles under inspection www.foxnews.com/health.
“This study is low and more research on this method is required as a potential treatment option for androgenetic alopecia.”
Until then, Camp encourages people to concentrate on currently available and “well -examined” treatments to tackle hair loss and visit one Dermatologist from the board for evaluation.
